Insulet Price to Book Ratio 2011-2025 | PODD
Historical price to book ratio values for Insulet (PODD) over the last 10 years. The current price to book ratio for Insulet as of November 12, 2025 is 16.58.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Insulet Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-11-12 | 336.84 | 16.21 | |
| 2025-06-30 | 314.18 | $20.78 | 15.12 |
| 2025-03-31 | 262.61 | $18.91 | 13.89 |
| 2024-12-31 | 261.07 | $17.26 | 15.13 |
| 2024-09-30 | 232.75 | $15.94 | 14.60 |
| 2024-06-30 | 201.80 | $14.24 | 14.17 |
| 2024-03-31 | 171.40 | $11.29 | 15.18 |
| 2023-12-31 | 216.98 | $10.48 | 20.70 |
| 2023-09-30 | 159.49 | $8.70 | 18.33 |
| 2023-06-30 | 288.34 | $7.94 | 36.34 |
| 2023-03-31 | 318.96 | $7.21 | 44.21 |
| 2022-12-31 | 294.39 | $6.85 | 42.95 |
| 2022-09-30 | 229.40 | $6.16 | 37.21 |
| 2022-06-30 | 217.94 | $6.09 | 35.80 |
| 2022-03-31 | 266.39 | $6.44 | 41.34 |
| 2021-12-31 | 266.07 | $8.04 | 33.09 |
| 2021-09-30 | 284.23 | $7.22 | 39.34 |
| 2021-06-30 | 274.51 | $6.69 | 41.02 |
| 2021-03-31 | 260.92 | $8.84 | 29.52 |
| 2020-12-31 | 255.63 | $9.14 | 27.96 |
| 2020-09-30 | 236.59 | $9.03 | 26.19 |
| 2020-06-30 | 194.26 | $8.59 | 22.62 |
| 2020-03-31 | 165.68 | $0.94 | 177.08 |
| 2019-12-31 | 171.20 | $1.21 | 141.39 |
| 2019-09-30 | 164.93 | $2.44 | 67.68 |
| 2019-06-30 | 119.38 | $4.15 | 28.75 |
| 2019-03-31 | 95.09 | $3.75 | 25.36 |
| 2018-12-31 | 79.32 | $3.58 | 22.14 |
| 2018-09-30 | 105.95 | $3.35 | 31.62 |
| 2018-06-30 | 85.70 | $3.04 | 28.21 |
| 2018-03-31 | 86.68 | $2.90 | 29.84 |
| 2017-12-31 | 69.00 | $2.72 | 25.39 |
| 2017-09-30 | 55.08 | $1.28 | 43.14 |
| 2017-06-30 | 51.31 | $1.12 | 46.01 |
| 2017-03-31 | 43.09 | $1.10 | 39.25 |
| 2016-12-31 | 37.68 | $1.10 | 34.28 |
| 2016-09-30 | 40.94 | $1.13 | 36.11 |
| 2016-06-30 | 30.24 | $0.48 | 63.08 |
| 2016-03-31 | 33.16 | $0.46 | 71.74 |
| 2015-12-31 | 37.81 | $0.60 | 63.24 |
| 2015-09-30 | 25.91 | $0.97 | 26.75 |
| 2015-06-30 | 30.99 | $1.24 | 25.09 |
| 2015-03-31 | 33.35 | $1.42 | 23.42 |
| 2014-12-31 | 46.06 | $1.49 | 30.93 |
| 2014-09-30 | 36.85 | $1.43 | 25.70 |
| 2014-06-30 | 39.67 | $1.40 | 28.27 |
| 2014-03-31 | 47.42 | $2.22 | 21.39 |
| 2013-12-31 | 37.10 | $2.27 | 16.34 |
| 2013-09-30 | 36.24 | $2.23 | 16.27 |
| 2013-06-30 | 31.41 | $2.55 | 12.34 |
| 2013-03-31 | 25.86 | $2.43 | 10.64 |
| 2012-12-31 | 21.22 | $0.91 | 23.23 |
| 2012-09-30 | 21.58 | $1.05 | 20.58 |
| 2012-06-30 | 21.37 | $1.23 | 17.33 |
| 2012-03-31 | 19.14 | $1.47 | 13.01 |
| 2011-12-31 | 18.83 | $1.74 | 10.81 |
| 2011-09-30 | 15.26 | $1.76 | 8.67 |
| 2011-06-30 | 22.17 | $1.99 | 11.13 |
| 2011-03-31 | 20.62 | $1.30 | 15.81 |
| 2010-12-31 | 15.50 | $1.46 | 10.63 |
| 2010-09-30 | 14.14 | $0.83 | 16.95 |
| 2010-06-30 | 15.05 | $1.10 | 13.73 |
| 2010-03-31 | 15.09 | $1.08 | 13.99 |
| 2009-12-31 | 14.28 | $1.64 | 8.71 |
| 2009-09-30 | 11.23 | $0.01 | 1145.92 |
| 2009-06-30 | 7.70 | $-0.12 | -61.90 |
| 2009-03-31 | 4.10 | $0.56 | 7.38 |
| 2008-12-31 | 7.72 | $1.01 | 7.63 |
| 2008-09-30 | 13.92 | $1.14 | 12.20 |
| 2008-06-30 | 15.73 | $1.85 | 8.50 |
| 2008-03-31 | 14.40 | $2.67 | 5.38 |
| 2007-12-31 | 23.48 | $3.39 | 6.93 |
| 2007-09-30 | 21.75 | $3.64 | 5.97 |
| 2007-06-30 | 14.20 | $4.16 | 3.41 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $22.953B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $220.837B | 25.45 |
| EssilorLuxottica (ESLOY) | France | $169.692B | 0.00 |
| Boston Scientific (BSX) | United States | $151.950B | 34.75 |
| Stryker (SYK) | United States | $139.087B | 27.62 |
| Medtronic (MDT) | Ireland | $122.368B | 17.25 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.739B | 0.00 |
| Agilent Technologies (A) | United States | $42.361B | 27.42 |
| ResMed (RMD) | United States | $36.840B | 25.50 |
| GE HealthCare Technologies (GEHC) | United States | $33.440B | 15.99 |
| Koninklijke Philips (PHG) | Netherlands | $28.242B | 18.45 |
| Terumo (TRUMY) | Japan | $24.252B | 28.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.539B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.204B | 0.00 |
| Baxter (BAX) | United States | $9.382B | 7.57 |
| Sunny Optical Technology (SNPTF) | China | $9.339B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.452B | 30.39 |
| Demant (WILYY) | Denmark | $7.496B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.539B | 10.78 |
| ICU Medical (ICUI) | United States | $3.536B | 22.45 |
| Haemonetics (HAE) | United States | $3.358B | 14.94 |
| Envista Holdings (NVST) | United States | $3.323B | 19.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.913B | 13.28 |
| LeMaitre Vascular (LMAT) | United States | $2.050B | 41.26 |
| Perrigo (PRGO) | Ireland | $1.968B | 4.93 |
| Curaleaf Holdings (CURLF) | Canada | $1.896B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.837B | 18.35 |
| AtriCure (ATRC) | United States | $1.634B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.504B | 65.91 |
| QuidelOrtho (QDEL) | United States | $1.487B | 9.56 |
| Tilray Brands (TLRY) | Canada | $1.448B | 0.00 |
| Neogen (NEOG) | United States | $1.419B | 27.21 |
| Kestra Medical Technologies (KMTS) | United States | $1.418B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.291B | 18.71 |
| BioLife Solutions (BLFS) | United States | $1.254B | 372.00 |
| InMode (INMD) | Israel | $0.917B | 10.36 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.830B | 0.00 |
| Valneva SE (VALN) | France | $0.764B | 0.00 |
| Surmodics (SRDX) | United States | $0.585B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.517B | 17.80 |
| SNDL (SNDL) | Canada | $0.486B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.481B | 0.00 |
| Omeros (OMER) | United States | $0.469B | 0.00 |
| CeriBell (CBLL) | United States | $0.464B | 0.00 |
| Evolus (EOLS) | United States | $0.453B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.431B | 0.00 |
| Cerus (CERS) | United States | $0.317B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.303B | 0.00 |
| Brainsway (BWAY) | Israel | $0.288B | 50.60 |
| Canopy Growth (CGC) | Canada | $0.288B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.283B | 0.00 |
| High Tide (HITI) | Canada | $0.261B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 151.67 |
| Sanara MedTech (SMTI) | United States | $0.250B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.241B | 19.24 |
| Quanterix (QTRX) | United States | $0.234B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.224B | 0.00 |
| Organigram Global (OGI) | Canada | $0.221B | 0.00 |
| Owens & Minor (OMI) | United States | $0.220B | 2.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.216B | 0.00 |
| Exagen (XGN) | United States | $0.209B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 16.16 |
| FitLife Brands (FTLF) | United States | $0.180B | 22.17 |
| OraSure Technologies (OSUR) | United States | $0.176B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| Biote (BTMD) | United States | $0.129B | 5.21 |
| Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.103B | 0.00 |
| Sharps Technology (STSS) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.099B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 13.33 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.057B | 33.00 |
| Nephros (NEPH) | United States | $0.046B | 33.31 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Zynex (ZYXI) | United States | $0.035B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.77 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |